v3.20.1
CONDENSED CONSOLIDATING FINANCIAL INFORMATION (Tables)
3 Months Ended
Mar. 31, 2020
CONDENSED CONSOLIDATING FINANCIAL INFORMATION  
Schedule of Condensed Statements of Operations

Condensed Consolidating Statement of Operations

Three Months Ended March 31, 2020:

Subsidiary

Subsidiary

Consolidating

Consolidated

(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings

Revenues

    

    

    

    

    

Admissions

$

$

389.1

$

178.9

$

$

568.0

Food and beverage

 

 

216.6

 

71.5

 

 

288.1

Other theatre

 

 

55.6

 

29.8

 

 

85.4

Total revenues

 

 

661.3

 

280.2

 

 

941.5

Operating costs and expenses

Film exhibition costs

 

 

198.9

 

72.8

 

 

271.7

Food and beverage costs

 

 

34.9

 

18.5

 

 

53.4

Operating expense, excluding depreciation and amortization

 

 

251.9

 

105.0

 

 

356.9

Rent

 

 

174.4

 

63.4

 

 

237.8

General and administrative:

Merger, acquisition and other costs

 

 

0.3

 

(0.1)

 

 

0.2

Other, excluding depreciation and amortization

 

 

17.3

 

15.9

 

 

33.2

Depreciation and amortization

 

92.4

 

30.1

 

 

122.5

Impairment of long-lived assets, indefinite-lived intangible assets and goodwill

 

 

1,214.3

 

637.6

 

 

1,851.9

Operating costs and expenses

 

 

1,984.4

 

943.2

 

 

2,927.6

Operating loss

 

 

(1,323.1)

 

(663.0)

 

 

(1,986.1)

Other expense (income):

Equity in net loss of subsidiaries

 

2,158.2

 

744.2

 

 

(2,902.4)

 

Other expense

20.2

5.3

1.4

26.9

Interest expense:

Corporate borrowings

 

70.7

 

71.0

 

0.8

 

(71.2)

 

71.3

Financing lease obligations

 

 

0.4

 

1.2

 

 

1.6

Non-cash NCM exhibitor service agreement

9.9

9.9

Intercompany interest expense

6.0

(6.0)

Equity in loss of non-consolidated entities

 

 

1.9

 

1.0

 

 

2.9

Investment expense (income)

 

(72.8)

 

5.3

 

(0.3)

 

77.2

 

9.4

Total other expense, net

 

2,176.3

 

838.0

 

10.1

 

(2,902.4)

 

122.0

Loss before income taxes

 

(2,176.3)

 

(2,161.1)

 

(673.1)

 

2,902.4

 

(2,108.1)

Income tax provision (benefit)

 

 

(2.9)

 

71.1

 

 

68.2

Net loss

$

(2,176.3)

$

(2,158.2)

$

(744.2)

$

2,902.4

$

(2,176.3)

Condensed Consolidating Statement of Operations

Three Months Ended March 31, 2019:

Subsidiary

Subsidiary

Consolidating

Consolidated

(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings

Revenues

    

    

    

    

    

    

    

    

    

    

Admissions

$

$

515.4

$

216.1

$

$

731.5

Food and beverage

 

 

287.6

 

81.2

 

 

368.8

Other theatre

 

 

64.2

 

35.9

 

 

100.1

Total revenues

 

 

867.2

 

333.2

 

 

1,200.4

Operating costs and expenses

Film exhibition costs

 

 

277.3

 

88.0

 

 

365.3

Food and beverage costs

 

 

43.0

 

18.5

 

 

61.5

Operating expense, excluding depreciation and amortization

 

 

285.6

 

117.2

 

 

402.8

Rent

 

 

176.6

 

65.4

 

 

242.0

General and administrative:

Merger, acquisition and other costs

 

 

1.2

 

2.1

 

 

3.3

Other, excluding depreciation and amortization

 

 

27.5

 

18.7

 

 

46.2

Depreciation and amortization

 

 

83.6

 

29.4

 

 

113.0

Operating costs and expenses

 

 

894.8

 

339.3

 

 

1,234.1

Operating loss

 

 

(27.6)

 

(6.1)

 

 

(33.7)

Other expense (income):

Equity in net loss of subsidiaries

 

294.7

 

196.9

 

 

(491.6)

 

Other expense

28.9

0.5

0.4

29.8

Interest expense:

Corporate borrowings

 

70.8

 

71.0

 

0.7

 

(71.2)

 

71.3

Finance lease obligations

 

 

0.7

 

1.4

 

 

2.1

Non-cash NCM exhibitor service agreement

10.2

10.2

Intercompany interest expense

197.5

(197.5)

Equity in earnings of non-consolidated entities

 

 

(6.1)

 

(0.4)

 

 

(6.5)

Investment income

 

(264.2)

 

(9.6)

 

(11.0)

 

268.7

 

(16.1)

Total other expense

 

130.2

 

263.6

 

188.6

 

(491.6)

 

90.8

Loss before income taxes

 

(130.2)

 

(291.2)

 

(194.7)

 

491.6

 

(124.5)

Income tax provision

 

 

3.5

 

2.2

 

 

5.7

Net loss

$

(130.2)

$

(294.7)

$

(196.9)

$

491.6

$

(130.2)

Schedule of Condensed Statements of Comprehensive Loss

Condensed Consolidating Statement of Comprehensive Loss

Three Months Ended March 31, 2020:

Subsidiary

Subsidiary

Consolidating

Consolidated

 

(In millions)

    

Holdings

    

Guarantors

    

Non-Guarantors

    

Adjustments

    

Holdings

 

Net loss

    

$

(2,176.3)

    

$

(2,158.2)

    

$

(744.2)

    

$

2,902.4

    

$

(2,176.3)

Other comprehensive loss:

Equity in other comprehensive loss of subsidiaries

 

(93.5)

 

(108.6)

 

 

202.1

 

Unrealized foreign currency translation adjustments, net of tax

 

 

15.1

 

(108.7)

 

 

(93.6)

Pension adjustments:

Realized net loss reclassified into other expense, net of tax

0.1

0.1

Other comprehensive loss

 

(93.5)

 

(93.5)

 

(108.6)

 

202.1

 

(93.5)

Total comprehensive loss

$

(2,269.8)

$

(2,251.7)

$

(852.8)

$

3,104.5

$

(2,269.8)

Condensed Consolidating Statement of Comprehensive Loss

Three Months Ended March 31, 2019:

Subsidiary

Subsidiary

Consolidating

Consolidated

 

(In millions)

    

Holdings

    

Guarantors

    

Non-Guarantors

    

Adjustments

    

Holdings

 

Net loss

    

$

(130.2)

    

$

(294.7)

    

$

(196.9)

    

$

491.6

    

$

(130.2)

Other comprehensive loss:

Equity in other comprehensive loss of subsidiaries

 

(24.9)

 

(15.6)

 

 

40.5

 

Unrealized foreign currency translation adjustments, net of tax

 

 

(9.7)

 

(15.7)

 

 

(25.4)

Realized loss on foreign currency transactions reclassified into other expense, net of tax

0.5

0.5

Pension adjustments:

Realized net loss reclassified into other expense, net of tax

0.1

0.1

Equity method investee's cash flow hedge:

 

Unrealized net holding loss arising during the period, net of tax

 

 

(0.1)

 

 

 

(0.1)

Other comprehensive loss

 

(24.9)

 

(24.9)

 

(15.6)

 

40.5

 

(24.9)

Total comprehensive loss

$

(155.1)

$

(319.6)

$

(212.5)

$

532.1

$

(155.1)

Schedule of Condensed Balance Sheets

Condensed Consolidating Balance Sheet

As of March 31, 2020:

Subsidiary

Subsidiary

Consolidating

Consolidated

(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings

Assets

    

    

    

    

    

    

    

    

    

    

Current assets:

Cash and cash equivalents

$

0.5

$

129.1

$

170.2

$

$

299.8

Restricted cash

10.0

10.0

Receivables, net

 

 

57.6

 

79.5

 

(10.3)

 

126.8

Other current assets

 

 

82.0

 

33.2

 

 

115.2

Total current assets

 

0.5

 

268.7

 

292.9

 

(10.3)

 

551.8

Investment in equity of subsidiaries

 

877.2

 

996.1

 

 

(1,873.3)

 

Property, net

 

 

1,889.2

 

631.2

 

 

2,520.4

Operating lease right-of-use assets, net

3,402.6

1,199.7

4,602.3

Intangible assets, net

 

 

121.7

 

53.4

 

 

175.1

Intercompany advances

 

3,002.5

 

(2,623.7)

 

(378.8)

 

 

Goodwill

 

(2.1)

 

1,949.8

 

990.3

 

 

2,938.0

Deferred tax asset, net

 

 

 

0.5

 

 

0.5

Other long-term assets

 

26.8

 

310.8

 

112.6

 

 

450.2

Total assets

$

3,904.9

$

6,315.2

$

2,901.8

$

(1,883.6)

$

11,238.3

Liabilities and Stockholders’ Equity

Current liabilities:

Accounts payable

$

$

157.2

$

190.3

$

(10.4)

$

337.1

Accrued expenses and other liabilities

 

47.9

 

124.8

 

90.2

 

0.1

 

263.0

Deferred revenues and income

 

 

320.6

 

79.7

 

 

400.3

Current maturities of corporate borrowings

 

20.0

 

 

 

 

20.0

Current maturities of finance lease liabilities

5.3

4.9

10.2

Current maturities of operating lease liabilities

453.2

128.3

581.5

Total current liabilities

 

67.9

 

1,061.1

 

493.4

 

(10.3)

 

1,612.1

Corporate borrowings

 

4,911.0

 

 

109.8

 

 

5,020.8

Finance lease liabilities

 

 

12.7

 

72.3

 

 

85.0

Operating lease liabilities

3,621.1

1,163.2

4,784.3

Exhibitor services agreement

 

 

550.4

 

 

 

550.4

Deferred tax liability, net

27.6

20.1

47.7

Other long-term liabilities

 

 

165.1

 

46.9

 

 

212.0

Total liabilities

 

4,978.9

 

5,438.0

 

1,905.7

 

(10.3)

 

12,312.3

Stockholders’ equity (deficit)

 

(1,074.0)

 

877.2

 

996.1

 

(1,873.3)

 

(1,074.0)

Total liabilities and stockholders’ equity

$

3,904.9

$

6,315.2

$

2,901.8

$

(1,883.6)

$

11,238.3

Condensed Consolidating Balance Sheet

As of December 31, 2019:

Subsidiary

Subsidiary

Consolidating

Consolidated

(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings

Assets

    

    

    

    

    

    

    

    

    

    

Current assets:

Cash and cash equivalents

$

0.3

$

94.9

$

169.8

$

$

265.0

Restricted cash

10.5

10.5

Receivables, net

 

 

160.1

 

104.0

 

(9.9)

 

254.2

Other current assets

 

 

108.5

 

34.9

 

 

143.4

Total current assets

 

0.3

 

363.5

 

319.2

 

(9.9)

 

673.1

Investment in equity of subsidiaries

 

452.6

 

1,962.8

 

 

(2,415.4)

 

Property, net

 

 

1,969.3

 

679.9

 

 

2,649.2

Operating lease right-of-use assets, net

3,491.8

1,304.2

4,796.0

Intangible assets, net

 

 

130.6

 

64.7

 

 

195.3

Intercompany advances

 

5,488.0

 

(5,097.7)

 

(390.3)

 

 

Goodwill

 

(2.1)

 

3,074.7

 

1,716.5

 

 

4,789.1

Deferred tax asset, net

 

 

 

70.1

 

 

70.1

Other long-term assets

 

47.4

 

328.0

 

127.6

 

 

503.0

Total assets

$

5,986.2

$

6,223.0

$

3,891.9

$

(2,425.3)

$

13,675.8

Liabilities and Stockholders’ Equity

Current liabilities:

Accounts payable

$

$

382.8

$

170.5

$

(10.0)

$

543.3

Accrued expenses and other liabilities

 

18.6

 

184.0

 

121.9

 

0.1

 

324.6

Deferred revenues and income

 

 

348.9

 

100.3

 

 

449.2

Current maturities of corporate borrowings

20.0

20.0

Current maturities of finance lease liabilities

5.3

5.0

10.3

Current maturities of operating lease liabilities

 

 

449.5

 

136.3

 

 

585.8

Total current liabilities

 

38.6

 

1,370.5

 

534.0

 

(9.9)

 

1,933.2

Corporate borrowings

 

4,733.4

 

 

 

 

4,733.4

Finance lease obligations

 

 

13.9

 

75.7

 

 

89.6

Operating lease liabilities

3,666.8

1,247.0

4,913.8

Exhibitor services agreement

 

 

549.7

 

 

 

549.7

Deferred tax liability, net

26.8

19.2

46.0

Other long-term liabilities

 

 

142.7

 

53.2

 

 

195.9

Total liabilities

 

4,772.0

 

5,770.4

 

1,929.1

 

(9.9)

 

12,461.6

Stockholders’ equity

 

1,214.2

 

452.6

 

1,962.8

 

(2,415.4)

 

1,214.2

Total liabilities and stockholders’ equity

$

5,986.2

$

6,223.0

$

3,891.9

$

(2,425.3)

$

13,675.8

Schedule of Condensed Statements of Cash Flows

Condensed Consolidating Statement of Cash Flows

Three Months Ended March 31, 2020:

Subsidiary

Subsidiary

Consolidating

Consolidated

(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings

Cash flows from operating activities:

  

    

  

    

  

    

  

    

  

    

Net cash provided by (used in) operating activities

$

35.2

$

(259.6)

$

40.4

$

$

(184.0)

Cash flows from investing activities:

Capital expenditures

 

 

(56.9)

 

(34.8)

 

 

(91.7)

Proceeds from disposition of long-term assets

 

 

3.1

 

0.3

 

 

3.4

Other, net

 

 

0.9

 

 

 

0.9

Net cash used in investing activities

 

 

(52.9)

 

(34.5)

 

 

(87.4)

Cash flows from financing activities:

Borrowings under revolving credit facilities

215.0

110.1

325.1

Scheduled principal payments under Term Loans

(5.0)

(5.0)

Principal payments under finance lease obligations

(1.3)

(1.0)

(2.3)

Cash used to pay deferred financing costs

 

(0.1)

 

 

 

 

(0.1)

Cash used to pay dividends

 

(4.3)

 

 

 

 

(4.3)

Taxes paid for restricted unit withholdings

(1.0)

(1.0)

Change in intercompany advances

(201.5)

308.7

(107.2)

Net cash provided by financing activities

 

3.1

 

307.4

 

1.9

 

 

312.4

Effect of exchange rate changes on cash and cash equivalents and restricted cash

 

(38.1)

 

39.3

 

(7.9)

 

 

(6.7)

Net increase (decrease) in cash and cash equivalents and restricted cash

0.2

 

34.2

 

(0.1)

 

 

34.3

Cash and cash equivalents and restricted cash at beginning of period

 

0.3

 

94.9

 

180.3

 

 

275.5

Cash and cash equivalents and restricted cash at end of period

$

0.5

$

129.1

$

180.2

$

$

309.8

Condensed Consolidating Statement of Cash Flows

Three Months Ended March 31, 2019:

Subsidiary

Subsidiary

Consolidating

Consolidated

(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings

Cash flows from operating activities:

    

    

    

    

    

    

    

    

    

    

Net cash provided by (used in) operating activities

$

228.0

$

(231.3)

$

4.7

$

$

1.4

Cash flows from investing activities:

Capital expenditures

 

 

(75.6)

 

(39.2)

 

 

(114.8)

Proceeds from disposition of long-term assets

3.9

13.4

17.3

Investments in non-consolidated entities, net

 

 

(0.1)

 

 

 

(0.1)

Other, net

 

 

(0.9)

 

 

 

(0.9)

Net cash used in investing activities

 

 

(72.7)

 

(25.8)

 

 

(98.5)

Cash flows from financing activities:

Repayments under revolving credit facilities

(3.8)

(3.8)

Scheduled principal payments under Term Loans

 

(3.4)

 

 

 

 

(3.4)

Principal payments under finance lease obligations

(2.5)

(1.3)

(3.8)

Cash used to pay dividends

 

(21.8)

 

 

 

 

(21.8)

Taxes paid for restricted unit withholdings

(1.1)

(1.1)

Change in intercompany advances

(219.6)

242.9

(23.3)

Net cash provided by (used in) financing activities

 

(245.9)

 

240.4

 

(28.4)

 

 

(33.9)

Effect of exchange rate changes on cash and cash equivalents and restricted cash

 

17.9

 

(17.6)

 

1.9

 

 

2.2

Net decrease in cash and cash equivalents and restricted cash

 

(81.2)

 

(47.6)

 

 

(128.8)

Cash and cash equivalents and restricted cash at beginning of period

 

0.3

 

177.7

 

146.0

 

 

324.0

Cash and cash equivalents and restricted cash at end of period

$

0.3

$

96.5

$

98.4

$

$

195.2